Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 68   

Articles published

JNJ 102.09 -0.17 (-0.17%)
price chart
J.&J. Names Outsider to Run Its Troubled Consumer Unit
Johnson & Johnson named an outsider on Thursday to fill a top leadership role overseeing its troubled consumer health unit, a break from the company's longstanding tradition of promoting executives from within.
J&J Recruits Bayer Executive  Wall Street Journal
Ms. Fix-it? Johnson & Johnson Goes Outside, Hires Bayer Exec to Run ...  YCharts
Related articles »  
Johnson & Johnson to open life science centres
Johnson & Johnson is to open four life science �innovation centres� as it decentralises decisions on investment and partnerships to boost productivity.
Johnson & Johnson sets up SF center  San Francisco Chronicle
Johnson & Johnson Announces Plans to Establish Innovation Centers  PR Newswire (press release)
Related articles »  
Lawyers in Risperdal case argue Johnson & Johnson's CEO should be called to ...
Johnson & Johnson's top executive should be forced to testify about claims that the company illegally marketed the antipsychotic drug Risperdal, which allegedly caused boys to grow breasts, lawyers for a teenager suing the drugmaker said in a court filing.
J&J's Alex Gorsky testify? Much too busy....on the other side of the ...  Philadelphia Inquirer (blog)
Related articles »  
Johnson & Johnson settles on first day of Philly Risperdal trial
A jury was picked and the trial was about to begin Monday morning in Philadelphia Common Pleas Court when Johnson & Johnson's Janssen Pharmaceuticals subsidiary settled a lawsuit with a Texas man who said he grew breasts as a child after being ...
J&J Sees Male Breasts And Quickly Settles Risperdal Suit  Forbes
J&J Settles Pa. Risperdal Lawsuit On Opening Day of Trial  Law360 (subscription)
Related articles »  
Lawyer Fights $10 Million Fee For "Cosmetic" Johnson And Johnson Settlement
Since this is a so-called derivative action filed on behalf of Johnson & Johnson itself, the settlement would actually cost their clients $10 million, on top of the millions of dollars the medical-products giant has already paid the government to ...
Johnson & Johnson Launches Be Vital Challenge to Reward College Student ...
NEW BRUNSWICK, N.J., Sept. 18, 2012 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) is launching a challenge to reward college student organizations for their effort in taking care of the world we share.
Related articles »  
Procter & Gamble Takes Over #11 Spot From Johnson & Johnson
But comparing market capitalization (factoring in those share counts) creates a true �apples-to-apples� comparison of the value of two stocks.
Johnson & Johnson - Life After The Patent Cliff?
Johnson & Johnson (NYSE:JNJ) saw the patents for its antibiotic, Levaquin (Floxin), and its ADHD/ADD drug, Concerta, expire in 2011.
Related articles »  
Johnson & Johnson Report: 54% of Hospitals Say Green Attributes Important in ...
More than one-third (35 percent) of hospitals surveyed switched suppliers to gain access to sustainable health-care products, according to a new report by Johnson & Johnson that finds hospitals are placing greater emphasis on �green� products used in ...
Future Impact of Environmental Scorecards, Hospital Global Purchasing ...  CSRwire.com (press release)
Related articles »  
$0 shareholder derivative settlement in Johnson & Johnson
Alison Frankel recently asked whether it's the end of "money-for-nothing" class actions. The Center for Class Action Fairness is putting that question to the test in In re Johnson & Johnson Shareholder Derivative Litigation by asking the District of ...